Loading clinical trials...
Loading clinical trials...
Placebo-controlled Efficacy and Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)
Conditions
Interventions
Neridronic acid 100 mg
Placebo
Locations
71
United States
US446 - Clinical Trial Connection
Cottonwood, Arizona, United States
US453 - Physicians Research Group II, LLC
Tempe, Arizona, United States
US428 - Quality of Life Medical and Research Center LLC
Tucson, Arizona, United States
US422 - Woodland International Research Group
Little Rock, Arkansas, United States
US454 - Alliance Research Institute
Canoga Park, California, United States
US415 - Clearview Medical Research LLC
Canyon Country, California, United States
Start Date
May 31, 2018
Primary Completion Date
August 1, 2019
Completion Date
August 1, 2019
Last Updated
August 5, 2020
Lead Sponsor
Grünenthal GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions